Abstract
AbstractBackgroundThe ePSOM programme is a collaboration between the University of Edinburgh and Alzheimer’s Research UK. prompted by the recognition that outcome measures currently used in clinical trials in prodromal and preclinical neurodegenerative diseases do not capture the research participants’ views of effectiveness. This led to a 4‐stage programme. [1] Evidence review and programme methodology [2] Focus groups to identify key domains of importance to people at various degrees of neurodegenerative disease [3] National online survey and [4] App development which can be used as an outcome measure in trials. Here we present stage [3] of the programme.MethodThe online survey captured free text responses in 5 predefined domains. Self‐reported clinical details and sociodemographic data were captured to analyse responses by key variables whilst keeping the survey short (around 15 minutes). The survey received ethical approval and ran August – November 2019. Using clustering and natural language processing techniques we identified clusters of response by domain and across domains. A specific question about the steps individuals take to ‘maintain brain health’ was also included.Result5807 people completed the survey. Most were female (76.9%), married (63.4%) and living in an urban area (61.8%). The mean age in women was 57.35 (SD=13.8) and 62.88 (SD=13.08) in men. 73% had supported a relative with dementia but only 15.4% had sought help for their own brain health. On a 10‐point scale (10 = best level of health), the mean score for self‐rated brain health was 9.32 (SD=1.97). We consider that the population undertaking the survey was exactly as intended as a primary or secondary prevention population. Thirty distinct clusters of response were identified across all domain and will be presented. The most common activities undertaken to maintain brain health were ‘trying to keep brain active’ (86.6%) followed by ‘trying to keep physically active’ (70.8%).ConclusionThe survey was successful in capturing a large number of people from a population at higher risk of neurodegenerative disease. The respondents understood the objectives of the survey and relevant clusters and items emerged which will guide the 4th phase of App development.
Highlights
The electronic Person-Specific Outcome Measure (ePSOM) development programme is a collaboration between the University of Edinburgh and Alzheimer’s Research UK prompted by the recognition that outcome measures currently used in clinical trials in prodromal and preclinical neurodegenerative diseases do not capture the research participants’ views of effectiveness
Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation
Background: The ePSOM development programme is a collaboration between the University of Edinburgh and Alzheimer’s Research UK prompted by the recognition that outcome measures currently used in clinical trials in prodromal and preclinical neurodegenerative diseases do not capture the research participants’ views of effectiveness
Summary
The ePSOM development programme is a collaboration between the University of Edinburgh and Alzheimer’s Research UK prompted by the recognition that outcome measures currently used in clinical trials in prodromal and preclinical neurodegenerative diseases do not capture the research participants’ views of effectiveness. The electronic person specific outcome measure (ePSOM) programme: Overview and survey results Citation for published version: Saunders, S, Sheehan, S, Evans, A, Luz, S, Ritchie, CW & Terrera, GM 2020, 'The electronic person specific outcome measure (ePSOM) programme: Overview and survey results: Neuropsychiatry and behavioral neurology/treatment development and clinical trials', Alzheimer's & Dementia, vol 16, no.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.